[Prophylactic treatment of hemophilia B. Considerations a propos of a personal study].
作者信息
Cortellaro M, Praga C
出版信息
Haematol Lat. 1969 Jul-Dec;12(3):651-7.
PMID:5396830
Abstract
摘要
相似文献
1
[Prophylactic treatment of hemophilia B. Considerations a propos of a personal study].
Haematol Lat. 1969 Jul-Dec;12(3):651-7.
2
Clinical use of human prothrombin complexes.
N Engl J Med. 1965 Sep 23;273(13):667-74. doi: 10.1056/NEJM196509232731301.
3
Surgical care of patients with hereditary disorders of blood coagulation.
Mod Treat. 1968 Jan;5(1):61-83.
4
Activated prothrombin concentrate for patients with factor VIII inhibitors.
N Engl J Med. 1974 Jul 25;291(4):164-7. doi: 10.1056/NEJM197407252910402.
5
Editorial: Factor VIII inhibitors.
N Engl J Med. 1974 Jul 25;291(4):205. doi: 10.1056/NEJM197407252910412.
6
Therapeutic materials used in the treatment of coagulation defects.
Clin Haematol. 1979 Feb;8(1):183-206.
7
Management of Christmas disease and Stuart-Prower deficiency with a prothrombin-complex concentrate (factors II, VII, IX, X).
Bibl Haematol. 1968;29:1134-9. doi: 10.1159/000384751.
8
[The use of new hemostatic drug in dental practice].
Stomatologiia (Mosk). 1974 Jan-Feb;53(1):85-6.
9
Treatment of hemophilia B with a new clotting-factor concentrate.
N Engl J Med. 1969 Mar 13;280(11):581-6. doi: 10.1056/NEJM196903132801103.
10
Editorial: Treatment of hemophilic children who have factor VIII inhibitors.
J Pediatr. 1976 Feb;88(2):367-8. doi: 10.1016/s0022-3476(76)81037-2.
Zotero 插件